A detailed history of Act Capital Management, LLC transactions in Sqz Biotechnologies CO stock. As of the latest transaction made, Act Capital Management, LLC holds 16,000 shares of SQZ stock, worth $800. This represents 0.05% of its overall portfolio holdings.

Number of Shares
16,000
Previous 16,000 -0.0%
Holding current value
$800
Previous $51,000 29.41%
% of portfolio
0.05%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$8.93 - $14.85 $53,580 - $89,100
-6,000 Reduced 27.27%
16,000 $143,000
Q3 2021

Nov 16, 2021

BUY
$11.46 - $15.77 $166,170 - $228,665
14,500 Added 193.33%
22,000 $317,000
Q2 2021

Aug 16, 2021

BUY
$11.32 - $14.45 $84,900 - $108,375
7,500 New
7,500 $109,000

Others Institutions Holding SQZ

About SQZ Biotechnologies Co


  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.